The U.S. Food and Drug Administration (FDA) has recently announced the release of two new features for cosmetic product registration and listing. These new Modernization of Cosmetics Reform Act of 2022 (MoCRA) features are designed to simplify the process of managing cosmetic product information for responsible persons.
- Discontinuation of Cosmetic Product Listing: This feature allows responsible persons to easily delist cosmetic products that are no longer on the market. By providing this option, the FDA aims to maintain accurate and up-to-date information.
- Relisting of Cosmetic Product: Conversely, the relisting feature enables responsible persons to reintroduce cosmetic products that were previously discontinued but are now being brought back to the market.
Key takeaway: the FDA has provided the ability to discontinue cosmetic products and reactivate old ones that were previously discontinued.
Keep in mind, if these features are used incorrectly, you risk products being deleted without the ability to be retrieved. Reed Tech offers a safer way to manage your entire product portfolio with SingleSource™ for Drug Products. Contact Reed Tech now to securely manage your Cosmetic Portfolio in SPL format.